United States Ophthalmic Market is Segmented By Drug Class (Anti-inflammatory Drugs, Anti-infective Drugs, Anti-glaucoma Drugs, Anti-VEGF Agents, and Others), By Dosage Form (Eye Drops, Ointments, Gels, Solutions, Injections, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Indication (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies). The report offers the value (in USD billion) for the above-mentioned segments.
Os principais jogadores que operam no mercado oftálmico dos Estados Unidos incluem Novartis AG, AbbVie, Merck & Co., Inc., Bausch Health Companies Inc., Santen Pharmaceutical Co., Ltd., Regeneron Pharmaceuticals, Inc., Sun Pharmaceutical Industries Ltd., Ocular Therapeutix, Inc., Alcon, KALA BIO, Aequus Pharmaceuticals, Omeros CorporationTakedano
United States Ophthalmic Market